Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04376125
Other study ID # 71441538L
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date June 30, 2020

Study information

Verified date May 2020
Source Universidad de León
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The researchers will carry out a randomized experimental study. Participants in the experimental group will receive a treatment based on suboccipital inhibition technique in addition to conventional treatment. Participants in the control group will only receive the conventional treatment. The existence of significant differences in both groups will be analyzed.


Description:

Conventional therapy will consist of microwaves, interference currents, and manual therapy.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date June 30, 2020
Est. primary completion date November 22, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- pathology tension headache associated with cervicalgia

Exclusion Criteria:

- pathology of nervous system

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Suboccipital inhibition in tension headache
Deep maneuver of myofascial induction in the suboccipital muscles

Locations

Country Name City State
Spain Cristina Blanco Ortega León

Sponsors (2)

Lead Sponsor Collaborator
Universidad de León SACyL

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Visual Analogue Scale for Pain a continuous scale comprised of a horizontal (HVAS) or vertical (VVAS) line, usually 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme: "no pain" (score of 0) and "worst imaginable pain" (score of 10) immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start
Secondary Change in Six-item Headache Impact Text A global measure of adverse headache impact. The final HIT-6 score is obtained from simple summation of the six items and ranges between 36 and 78, with larger scores reflecting greater impact. immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start
See also
  Status Clinical Trial Phase
Completed NCT05549765 - The Effectiveness of Pharmacopuncture on Acute Tension Headache N/A
Completed NCT03844412 - Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Phase 2
Not yet recruiting NCT06277063 - nVNS for the Prevention and Treatment of Primary Headache N/A
Completed NCT02882880 - Treatment Sleep Bruxism With the Luco Hybrid OSA Appliance N/A
Completed NCT00018811 - Psychological Assessment and Treatment of Chronic Benign Headache N/A